Category: Latest News
-
Novocure shares rise after Medicare billing privileges reinstated
Novocure Ltd (NASDAQ:NVCR) shares climbed about 4.3% in premarket trading Wednesday after the company said U.S. regulators restored its Medicare billing authorization, removing uncertainty around reimbursement for its cancer therapy services. The company announced that its U.S. subsidiary, Novocure Inc., received confirmation from the Centers for Medicare & Medicaid Services (CMS) that a previous revocation…
-
Whirlpool stock edges higher after equity raise despite activist backlash
Shares of Whirlpool Corp (NYSE:WHR) moved modestly higher in premarket trading Wednesday, gaining about 0.7% to $72.16, even as a prominent shareholder criticized the company’s recent capital raise. The appliance manufacturer said it had priced a public offering of roughly 6.9 million common shares at $69 each, generating approximately $475 million in proceeds. In addition,…
-
Rayonier Advanced Materials shares surge after AIP reveals 5.1% stake
Shares of Rayonier Advanced Materials Inc. (NYSE:RYAM) climbed about 13% after private equity firm American Industrial Partners (AIP) disclosed it had built a 5.1% position in the specialty materials producer. According to a Schedule 13D filing, AIP purchased roughly 3.4 million shares for about $25.4 million, excluding brokerage fees. The investment was financed using the…
-
Thomson Reuters shares gain after $600M buyback plan and capital return announcement
Thomson Reuters (NASDAQ:TRI) shares edged higher in premarket trading on Wednesday after the company unveiled plans to repurchase up to $600 million of its stock alongside a $605 million capital return to shareholders. The company said the share repurchases will be carried out under an amended normal course issuer bid authorized by the Toronto Stock…
-
Mint unveils first FLOKI Minibot M1 prototype, marking entry into consumer AI robotics
Mint Incorporation Limited (NASDAQ:MIMI) announced the successful delivery of the first prototype of its FLOKI Minibot M1, an artificial intelligence-powered companion robot developed in partnership with Rice Robotics Holdings Limited, signaling the Hong Kong-based company’s expansion into the consumer robotics market. The milestone represents Mint’s official move into the fast-growing business-to-consumer robotics segment as part…
-
Geron shares drop after Q4 results miss estimates despite Rytelo growth
Geron Corporation (NASDAQ:GERN) shares fell roughly 15% in premarket trading Wednesday after the oncology-focused biotech company reported fourth-quarter 2025 results that came in below Wall Street expectations while reaffirming its full-year guidance. The developer of blood cancer treatment Rytelo posted a net loss of $0.05 per share on revenue of $48.0 million for the quarter,…
-
NextPlat forecasts $55M 2025 revenue as restructuring drives margin expansion outlook
NextPlat Corp (NASDAQ:NXPL) said it expects to generate approximately $55 million in revenue for 2025 and anticipates continued operational improvement following strategic business refocusing efforts, with margin expansion and cost reductions projected to extend into 2026. The global consumer products and services company, which delivers healthcare and technology solutions through e-commerce and retail channels, reported…
-
Recursion Q4 earnings outperform, AI-driven drug discovery progress highlighted
Recursion Pharmaceuticals (NASDAQ:RXRX) reported fourth-quarter and full-year 2025 financial results alongside a business update, as the clinical-stage TechBio company emphasized progress in advancing its artificial intelligence–driven drug discovery platform. For the fourth quarter, Recursion posted earnings per share of $-0.21, outperforming analyst expectations of $-0.30 by $0.09. Revenue totaled $35.54 million, well above the consensus…
-
XWELL secures $31.3 million through private placement financing
XWELL, Inc. (NASDAQ:XWEL) announced it has entered into a securities purchase agreement with American Ventures, LLC for a private placement expected to generate approximately $31.3 million in gross proceeds before fees and expenses. The financing comes as the company navigates ongoing cash flow pressures, including levered free cash flow of negative $15.1 million over the…
-
CASI Pharmaceuticals to be delisted from Nasdaq effective Wednesday
CASI Pharmaceuticals Inc. (NASDAQ:CASI) announced Tuesday that its shares will be removed from trading on the Nasdaq Stock Market at the opening of business on Wednesday, February 26, 2026. The stock closed Tuesday at $0.76, near its 52-week low of $0.74, following a sharp 67% decline over the past six months. The clinical-stage biopharmaceutical company…